Search by Drug Name or NDC

    NDC 00469-2860-35 CRESEMBA 40 mg/1 Details

    CRESEMBA 40 mg/1

    CRESEMBA is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Astellas Pharma US, Inc.. The primary component is ISAVUCONAZONIUM SULFATE.

    Product Information

    NDC 00469-2860
    Product ID 0469-2860_a91d60a8-2fa7-4f5c-b10b-852309428863
    Associated GPIs
    GCN Sequence Number 085265
    GCN Sequence Number Description isavuconazonium sulfate CAPSULE 74.5 MG ORAL
    HIC3 W3B
    HIC3 Description ANTIFUNGAL AGENTS
    GCN 54696
    HICL Sequence Number 041817
    HICL Sequence Number Description ISAVUCONAZONIUM SULFATE
    Brand/Generic Brand
    Proprietary Name CRESEMBA
    Proprietary Name Suffix n/a
    Non-Proprietary Name isavuconazonium sulfate
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form CAPSULE
    Route ORAL
    Active Ingredient Strength 40
    Active Ingredient Units mg/1
    Substance Name ISAVUCONAZONIUM SULFATE
    Labeler Name Astellas Pharma US, Inc.
    Pharmaceutical Class Azole Antifungal [EPC], Azoles [CS], Cytochrome P450 3A4 Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA207500
    Listing Certified Through 2024-12-31

    Package

    NDC 00469-2860-35 (00469286035)

    NDC Package Code 0469-2860-35
    Billing NDC 00469286035
    Package 35 BLISTER PACK in 1 CARTON (0469-2860-35) / 1 CAPSULE in 1 BLISTER PACK
    Marketing Start Date 2022-11-22
    NDC Exclude Flag N
    Pricing Information N/A